Navigation Links
Option to Develop Exelixis Compound Exercised By Genentech
Date:3/14/2008

SOUTH SAN FRANCISCO, Calif., March 14 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today announced that Genentech, Inc. has exercised its option to further develop and commercialize Exelixis' compound XL518, a selective and potent inhibitor of MEK, which is currently in a phase 1 clinical trial. Under the terms of the collaboration agreement between the parties, Exelixis will continue to be responsible for the phase 1 clinical trial until the point that a maximum tolerated dose (MTD) is determined. After MTD is achieved, Genentech will be responsible for completing the phase 1 clinical trial and subsequent clinical development.

"MEK inhibition is an exciting approach to cancer therapy. The MAP kinase pathway, of which MEK is a member, is one of the most frequently dysregulated pathways in human tumors. Activating mutations of the pathway have been identified in many tumor types, including melanomas, thyroid carcinomas, non-small cell lung cancer and colon cancer. Pathway inhibitors are likely to find broad utility as both single agents and in combination with other targeted agents and chemotherapeutics," said George A. Scangos, PhD, president and chief executive officer of Exelixis. "I am pleased that Genentech shares our interest in the target and the compound. We believe the opt-in by Genentech is recognition of the potential of XL518 and MEK inhibition in the treatment of various tumor types," continued Dr. Scangos.

Under the terms of the collaboration agreement between Exelixis and Genentech, Exelixis received upfront and milestone payments totaling $40.0 million at the time the agreement was signed in January 2007. Selection of the compound and opt-in by Genentech trigger a payment of $3.0 million. Another $7
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
2. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
3. Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference
4. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
5. InterMune to Present at the SIGnificant Options in Healthcare Conference
6. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
7. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
10. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
11. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... University of Adelaide research may help in the fight ... can detect tiny quantities of explosives with the use ... the journal Sensors and Actuators B: Chemical , ... can detect explosives in concentrations as low as 6.3 ... of only a few minutes. , "Traditionally explosives detection ...
(Date:7/10/2014)... the basis of psychiatric disorders has been extremely challenging ... risk but are insufficient to cause disease. Now investigators ... Press journal Cell Stem Cell describe a ... risks interact with other risk factors or environmental exposures ... research pinpoints a genetic variant that may predispose individuals ...
(Date:7/10/2014)... down forever. Nanophysics makes sure of that. Mechanics researchers at ... in Physical Review E . Knowledge that can be ... to be able to sit still forever, and walk around ... will soon be able to buy smart new fasteners that ... fact is, sooner or later the grip is lost, no ...
(Date:7/10/2014)... see the two universities and NPL collaborate to bring ... industry and their complementary academic strengths., Working with BIS ... the scientific priorities of the UK. The establishment of ... high-calibre PhD students, will provide a pipeline of skilled ... of the Laboratory will be grown through the creation ...
Breaking Biology Technology:Detecting trace amounts of explosives with light 2New strategy could uncover genes at the root of psychiatric illnesses 2Even geckos can lose their grip 2Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 2Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 3
... applies to all of Dane County , , Editors ... and careers extends to all of Dane County. In an interview ... Best Places for Business and Careers ranking applies to the ... , , WTN: Can you tell us about some of ...
... MyWeather , a Madison-based provider of online weather services ... availability of a customizable desktop application, Live Online. The ... to alert their customers, prospects and employees of important ... provides users with more flexibility in how they handle ...
... a division of Charter Communications , announced Tuesday ... Berbee Information Networks by adding a ninth fiber-based ... Berbees data center in Fitchburg. , ,Rather than having ... vendors, Charter hands off 10 Mb Ethernet and provides ...
Cached Biology Technology:Forbes Sr. Editor Kurt Bandenhausen on Forbes ranking of top cities for business 2Charter and Berbee connect Pharmacy Cooperative 2
(Date:7/11/2014)... exists that cannabinoid receptor type 1 can ... influx, and reduce neurotransmitter release. However, some ... can increase extracellular Ca2+ influx and increase ... team, Tongji Hospital Affiliated to Tongji Medical ... China used whole cell voltage-clamp and calcium ...
(Date:7/10/2014)... SPRINGS, Colo. , June 27, 2014 /PRNewswire/ ... that the National Institute of Standards and Technology ... 10 of its academic research and forensic science ... (FSSB).  The Board is an element of the ... AAFS members are among the first appointments made ...
(Date:7/10/2014)... , July 2, 2014 It is a ... announce the appointment of the world-renowned Thoracic and Cardiovascular ... Directors. Dr. Ginsburg, with over 34 years ... Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. ... the late 1980,s and is considered an expert in ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
... paleoethnobotanist at the University of Missouri-Columbia, recently found fossil ... to present-day Peru that showed people were eating domesticated ... makes chili peppers one of the oldest domesticated food ... in the Feb. 15 edition of the journal Science. ...
... way out of Africa some 60,000 years ago to ... accompanied by the bacterium Helicobacter pylori, which causes gastritis ... spread throughout the entire world. This is the conclusion ... Mark Achtman from the Max Planck Institute for Infection ...
... people who are at risk of heart disease receive the ... new report published today (Wednesday 18 April) in the European ... with a rise in deaths from heart disease and that ... death. , However, only about 60% of people in the ...
Cached Biology News:Researchers find 6,000-year-old fossil evidence 2Out of Africa -- Bacteria, as well 2New research shows that flu is a trigger of heart attacks 2New research shows that flu is a trigger of heart attacks 3New research shows that flu is a trigger of heart attacks 4